Rising prevalence of infectious diseases and increasing demand for rapid and accurate diagnostic techniques are driving the growth of the isothermal nucleic acid amplification technology market.
Technological advancements in molecular diagnostics and the development of innovative products are expected to fuel market growth.
Adoption of point-of-care testing and increasing research activities in genomics and molecular biology are creating new opportunities for market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Technology, Application, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Alere,, bioMerieux SA, Eiken Chemical Co., Hologic(Gen-Probe), Lucigen, Meridian Bioscience,, Ustar Biotechnologies., QIAGEN, Quidel, Thermo Fisher Scientific, Inc, BD, OptiGene Limited |
High cost associated with isothermal nucleic acid amplification technology and limited awareness about its benefits among healthcare professionals are major restraints for market growth.
Challenges related to regulatory approval and standardization of isothermal nucleic acid amplification technology are also hindering market growth.